Relationship between body mass index and neuropsychiatric symptoms: Evidence and inflammatory correlates
- PMID: 33684502
- DOI: 10.1016/j.bbi.2021.02.031
Relationship between body mass index and neuropsychiatric symptoms: Evidence and inflammatory correlates
Abstract
Objective: Neuropsychiatric symptoms are frequent in obese individuals. Mounting evidence suggests that adiposity-related inflammation contributes to this effect. This study assessed the relationship between adiposity, neuropsychiatric symptom dimensions and systemic inflammation in subjects stratified by body-mass-index (BMI).
Methods: The study included 165 subjects, of whom 70 were very severely obese (BMI ≥ 40 kg/m2), 50 severely obese (BMI: 35-39.99 kg/m2), 21 overweight or moderately obese (BMI: 25-34.9 kg/m2), and 24 lean (BMI < 25 kg/m2). Depressive symptoms were assessed using the Montgomery-Asberg Depression Rating Scale (MADRS) and the Mini-International Neuropsychiatric Interview (MINI). Fatigue and general neurobehavioral symptoms were assessed using the Multidimensional Fatigue Inventory (MFI) and Neurotoxicity Rating Scale (NRS) respectively. Serum levels of the inflammatory markers, high-sensitive (hs) CRP and hsIL-6, were determined by ELISA.
Results: Severely obese subjects exhibited higher MADRS, MFI and NRS scores and were more frequently afflicted with current diagnosis of major depression than lean participants. Scores on psychometric scales were also increased in very severely obese subjects, although to a lesser extent. Alterations in neuropsychiatric dimensions were highly inter-related. HsCRP was significantly increased in subjects with severe or very severe obesity, while hsIL-6 was augmented in all obese groups. Overall, increased neuropsychiatric comorbidity was associated with greater systemic inflammation, notably hsCRP.
Conclusion: Obesity is characterized by an increased prevalence of inter-related neuropsychiatric symptoms together with low-grade systemic inflammation augmenting with adiposity. The association between adiposity, systemic inflammation and neuropsychiatric alterations supports the contribution of adiposity-related inflammatory processes to neuropsychiatric comorbidities in obesity. These data suggest that consideration of adiposity characteristics may help identifying subjects at increased risk for neuropsychiatric comorbidity.
Keywords: Depression; Inflammation; Neuropsychiatric symptoms; Obesity; Prevalence; Semiology.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.
Similar articles
-
History of major depression is associated with neuropsychiatric symptoms but not systemic inflammation in a cross-sectional study in obese patients.Brain Behav Immun. 2019 Feb;76:215-222. doi: 10.1016/j.bbi.2018.11.312. Epub 2018 Nov 23. Brain Behav Immun. 2019. PMID: 30476563
-
Depressive symptoms in obesity: Relative contribution of low-grade inflammation and metabolic health.Psychoneuroendocrinology. 2018 May;91:55-61. doi: 10.1016/j.psyneuen.2018.02.030. Epub 2018 Mar 6. Psychoneuroendocrinology. 2018. PMID: 29525586
-
Relationship between adiposity, emotional status and eating behaviour in obese women: role of inflammation.Psychol Med. 2011 Jul;41(7):1517-28. doi: 10.1017/S0033291710001984. Epub 2010 Oct 20. Psychol Med. 2011. PMID: 20961476
-
Depression and peripheral inflammatory profile of patients with obesity.Psychoneuroendocrinology. 2018 May;91:132-141. doi: 10.1016/j.psyneuen.2018.03.005. Epub 2018 Mar 9. Psychoneuroendocrinology. 2018. PMID: 29550676 Review.
-
Role of Adiposity-Driven Inflammation in Depressive Morbidity.Neuropsychopharmacology. 2017 Jan;42(1):115-128. doi: 10.1038/npp.2016.123. Epub 2016 Jul 11. Neuropsychopharmacology. 2017. PMID: 27402495 Free PMC article. Review.
Cited by
-
Changes in T-Cell Subpopulations and Cytokine Levels in Patients with Treatment-Resistant Depression-A Preliminary Study.Int J Mol Sci. 2022 Dec 28;24(1):479. doi: 10.3390/ijms24010479. Int J Mol Sci. 2022. PMID: 36613927 Free PMC article.
-
Composite immune marker scores associated with severe mental disorders and illness course.Brain Behav Immun Health. 2022 Jul 2;24:100483. doi: 10.1016/j.bbih.2022.100483. eCollection 2022 Oct. Brain Behav Immun Health. 2022. PMID: 35856063 Free PMC article.
-
Activation of the Monocyte/Macrophage System and Abnormal Blood Levels of Lymphocyte Subpopulations in Individuals with Autism Spectrum Disorder: A Systematic Review and Meta-Analysis.Int J Mol Sci. 2022 Nov 18;23(22):14329. doi: 10.3390/ijms232214329. Int J Mol Sci. 2022. PMID: 36430805 Free PMC article.
-
Causal association between major depressive disorder and venous thromboembolism: a bidirectional mendelian randomization study.Front Genet. 2024 Jun 25;15:1383333. doi: 10.3389/fgene.2024.1383333. eCollection 2024. Front Genet. 2024. PMID: 38983268 Free PMC article.
-
Sustained effects of repeated levodopa (L-DOPA) administration on reward circuitry, effort-based motivation, and anhedonia in depressed patients with higher inflammation.Brain Behav Immun. 2025 Mar;125:240-248. doi: 10.1016/j.bbi.2024.12.026. Epub 2024 Dec 16. Brain Behav Immun. 2025. PMID: 39694342 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous